🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to BIO-Europe — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
BIO-Europe 2026 | Global Biopharma Partnering Event
BIO-Europe is a global partnering event designed for the biopharma community, bringing together life science professionals to shape strategic relationships, advance innovation, and accelerate collaboration across therapeutic development and commercialization.
The 2026 edition will take place November 9–11, 2026 at Koelnmesse in Cologne, Germany, positioning the event as a central meeting point for biopharma leaders, dealmakers, and industry experts from around the world.
Why attend BIO-Europe
BIO-Europe is widely positioned as an “epicenter of biotech,” specifically framed as a European platform with worldwide reach. The event focuses on high-quality, strategic interactions—supported by structured one-to-one partnering meetings—and expands its program beyond partnering alone.
In 2026, BIO-Europe continues to set a standard for excellence in partnering while broadening its commitment to global collaboration. Alongside business development and deal activity, the program is expanded to include content and conversations covering:
- Regulatory developments affecting biopharma strategy
- Clinical affairs and clinical decision-making considerations
- Manufacturing strategy and biomanufacturing planning
- Comprehensive program tracks that expand how participants engage during the event
- Strategic conversations for biopharma C-suite and leadership teams
- New access options to support a variety of engagement levels
Who BIO-Europe brings together
BIO-Europe is designed to convene biotech, pharma, and investment leaders from a broad international footprint. The event is described as bringing together 8,000+ life science professionals, with participation from 60+ countries.
It emphasizes connecting experienced business development professionals and enabling participants to identify assets and opportunities that support long-term growth.
Partnering format and engagement
A core part of BIO-Europe is structured one-to-one partnering, supported by an event environment focused on strategic introductions rather than general networking. Participants also benefit from an industry-leading speaker program, including keynote panels, fireside chats, and exclusive insights.
Key program themes
The event content areas highlighted on the official page reflect a wide view of the biopharma value chain and strategic priorities, including:
- The Business of Biotech
- Regulatory
- Clinical Strategy
- Therapeutic Insights
- Biomanufacturing
- Ecosystem Innovation
Location and dates
Date: November 9–11, 2026
Venue: Koelnmesse
City/Country: Cologne, Germany
Data sheet
BIO-Europe – Event Attendee & Buyer Profile Analysis
Event Date: 9–11 November 2026 |
Location: Cologne, Germany |
Event Status: Upcoming |
Research Date: 30 June 2026
Event Overview
| Event Name | BIO-Europe 2026 |
| Event Date | 9–11 November 2026 |
| Event Status | Upcoming |
| Venue | Koelnmesse |
| City | Cologne |
| State / Region | North Rhine-Westphalia |
| Country | Germany |
| Organizer | Informa Connect |
| Official Event Website | informaconnect.com/bioeurope/ |
| Event Type | Global biopharma partnering event / conference / networking summit |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Business Services; IT & Technology |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | 8,000+ life science professionals (official website claim) |
| Attendance Data Reliability | High for claimed scale; final audited attendance not publicly confirmed by the organizer. |
| Main Purpose of Event | Partnering, business development, investment, strategic collaborations, regulatory discussion, clinical affairs, and biomanufacturing networking across the global biopharma ecosystem. |
About the Event
BIO-Europe is a leading global biopharma partnering event focused on deal-making, strategic collaboration, and business development across biotechnology, pharmaceuticals, investing, and enabling services. The 2026 edition in Cologne is positioned as a major European hub for one-to-one partnering meetings, executive networking, and content sessions spanning the business of biotech, regulatory developments, clinical strategy, and biomanufacturing.
The event matters because it draws senior decision-makers who influence licensing, partnerships, investment, outsourcing, technology adoption, and commercial growth. It is especially relevant for companies selling to biopharma leadership, CDMOs, venture-backed innovators, service providers, and organizations seeking partner discovery, sourcing opportunities, and pipeline expansion.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Biopharma BD / Licensing Teams | Pharma companies, biotech firms, pipeline holders | Partner identification, asset evaluation, deal negotiation | Core audience for partnering platforms, analytics, advisory, and deal support |
| C-Suite / Executive Leadership | Biotech CEOs, pharma presidents, general managers | Strategic partnership and investment decisions | High-value prospects for enterprise services, capital solutions, and strategic advisory |
| Investors / Venture Teams | Venture capital, corporate venture, growth equity | Capital allocation, syndication, diligence | Relevant for startups, advisory firms, and data/service providers |
| R&D / Scientific Leadership | Biotech R&D groups, translational teams, research institutes | Technology evaluation, collaboration, pipeline input | Strong fit for lab tools, CRO/CDMO, analytics, and research platforms |
| Clinical / Regulatory Teams | Clinical development, regulatory affairs organizations | Trial strategy, submissions, compliance planning | Targets for regulatory tech, clinical services, and compliance solutions |
| Manufacturing / CMC Leadership | Biomanufacturers, CDMOs, process development teams | Outsourcing, scale-up, manufacturing strategy | Relevant for equipment, quality, logistics, and manufacturing services |
| Business Development / Partnerships | Platform companies, solution providers, biotech networks | Lead generation, alliance formation, market entry | Directly aligned with event positioning and networking model |
| Service Providers / Enablers | CROs, CDMOs, legal firms, consultants, software vendors | Supplier selection, partnership building, client acquisition | Highly relevant for B2B lead generation and attendee list building |
| Association / Media / Ecosystem Leaders | Industry associations, publishers, life sciences media | Influence, visibility, community-building | Useful for sponsorship, PR, and ecosystem outreach |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Cologne / North Rhine-Westphalia | Local and regional attendees | Medium | Venue-city attendance from biotech, pharma, and service providers in the region |
| Germany | National biotech and pharma participants | High | Germany is a major life sciences market with strong pharma, biotech, and CDMO presence |
| Benelux / DACH / France / UK | Nearby European business hubs | High | Strong cross-border participation is expected for partnering and BD meetings |
| Nordics, Southern Europe, Central Europe | Broader European life sciences community | Medium to High | Relevant for partnership discovery and service-provider outreach |
| North America | Global biotech and investment attendees | High | Important for transatlantic partnering and venture / licensing activity |
| Asia-Pacific | International biopharma and manufacturing partners | Medium | Useful for sourcing, CDMO, licensing, and cross-border business development |
| Middle East / Rest of World | Selected strategic participants | Low to Medium | Typically smaller in volume but potentially high value for partnership deals |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | Official event messaging emphasizes global collaboration, 60+ countries, and international biopharma leadership. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Ovid Therapeutics Inc | Biopharma company | Confirmed 2026 featured speaker organization; relevant for partnership, licensing, and strategic sourcing. | ovidrx.com | CEO, CBO, Head of BD, VP Partnerships | Confirmed Speaker Organization |
| Angelini Ventures | Corporate venture / investor | Confirmed 2026 featured speaker organization; likely to evaluate pipeline companies and strategic collaborations. | angeliniindustries.com/en/angelini-ventures | Managing Director, Partner, Principal, Investment Director | Confirmed Speaker Organization |
| Roche Ventures | Corporate venture / investor | Confirmed 2026 featured speaker organization; active in biotech innovation and partnering ecosystems. | roche.com | Head of Venture, Investment Director, Partner, BD Lead | Confirmed Speaker Organization |
| WuXi AppTec | CDMO / service provider | Confirmed 2026 featured speaker organization; strong partnering relevance with biopharma buyers. | wuxiapptec.com | Co-CEO, VP BD, Alliance Manager, Commercial Director | Confirmed Speaker Organization |
Prior-year participation evidence. Not a confirmed attendee list for the current edition.
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Business Officer / Chief Development Officer / CEO | Executive | C-level | Owns strategic partnering, investment, and growth decisions. |
| 2 | VP Business Development / Head of BD / Licensing Director | Business Development | VP / Director | Primary relationship builders for partnering and deal sourcing. |
| 3 | Investment Director / Principal / Partner | Venture / Corporate Venture | Senior | Looks for scalable opportunities, platform technologies, and alliances. |
| 4 | Director Regulatory Affairs | Regulatory | Director | Relevant to companies offering regulatory strategy, software, and consulting. |
| 5 | Head of Clinical Development / Clinical Strategy Lead | Clinical Development | Senior / Director | Key for trial design, outsourcing, and study-support solutions. |
| 6 | Head of Biomanufacturing / CMC Director | Manufacturing / CMC | Senior / Director | Important for CDMO, process development, and supply chain vendors. |
| 7 | Alliance Manager / Partnership Manager | Partnerships | Manager / Senior Manager | Maintains active partner pipelines and follow-up after meetings. |
| 8 | CRO / CDMO Commercial Director | Commercial / Sales | Director / VP | Targets companies seeking outsourced development and manufacturing services. |
| 9 | Technology Scout / Innovation Director | Innovation / R&D | Director / Senior Director | Evaluates external innovation, enabling technology, and licensing opportunities. |
| 10 | Portfolio Manager / Associate / Analyst | Investment / Strategy | Mid-level | Supports diligence, company screening, and deal preparation. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Biotechnology | Core attendee base for partnering and pipeline development | Biotech licensing, BD, and scientific partnership outreach |
| 2 | Pharmaceuticals | Major buyer group for strategic alliances and outsourcing | Enterprise partnership, procurement, and innovation targeting |
| 3 | Medical Devices | Adjacent innovation and life sciences ecosystem relevance | Cross-sector strategic sourcing and partnership leads |
| 4 | Biotechnology Research | Supports scientific networking and innovation discovery | Research tool and platform solution selling |
| 5 | Venture Capital & Private Equity | Capital allocators attend for deal flow and diligence | Investor targeting and startup introduction campaigns |
| 6 | Investment Management | Relevant for funding, portfolio, and strategic capital conversations | Capital-markets and corporate-development outreach |
| 7 | Research | Scientific and translational research stakeholders attend in volume | Research platforms, analytics, and lab workflow offerings |
| 8 | Management Consulting | Advisory groups support BD, market access, and portfolio strategy | Consulting partners and referral-network development |
| 9 | Information Technology & Services | Digital tools for partnering, clinical, and R&D workflows | Software, data, and workflow-automation targeting |
| 10 | Hospital & Health Care | Clinical collaboration and translational relevance | Clinical partnership, trial, and care-network outreach |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | 8,000+ | Confirmed by organizer claim | Official event website | Attendance figure not publicly confirmed by the organizer beyond the “8,000+” statement. |
| Exhibitor count | Not publicly confirmed | Unconfirmed | Official website content reviewed | No verified exhibitor total found in supplied source text. |
| Buyer count | Not publicly confirmed | Unconfirmed | Official website content reviewed | Partnering event format suggests high buyer presence, but no audited count is published here. |
| Speaker count | Industry-leading speakers; exact count not publicly confirmed | Partially confirmed | Official event website content reviewed | Named 2026 speakers are published, but total speaker count is not shown in the supplied text. |
| Historical / prior-year attendance | Not assessed in this report | Not used | Current official website only | Current-year official website provides sufficient scale signal for lead generation planning. |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Partnering / BD | New licensing and strategic alliance opportunities | One-to-one meetings, lead qualification, partnership discovery | Partnering platforms, BD intelligence, CRM, outreach services |
| Investment | Deal flow, diligence, portfolio expansion | Target investors and investor-backed companies | Data rooms, market intelligence, advisory, investor relations |
| Regulatory | Submission strategy, compliance planning | Thought leadership and targeted follow-up to regulatory leaders | Regulatory consulting, compliance software, document management |
| Clinical Strategy | Trial design, site strategy, outsourcing | Identify clinical operations and development leaders | CRO services, clinical software, patient recruitment tools |
| Biomanufacturing | Scale-up, process development, capacity | Engage CDMO and manufacturing decision-makers | Equipment, QA/QC, supply chain, process analytics |
| Ecosystem Innovation | External innovation and platform scouting | Target innovation scouts and R&D leaders | Discovery tools, research services, AI and data platforms |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The event is built around partnering, investment, and biopharma decision-makers. |
| Decision-maker availability | High | Executive, BD, investment, and scientific leaders are core attendees. |
| Data collection potential | High | Partnering agendas and sponsor ecosystems support list-building and account targeting. |
| Apollo targeting potential | Very High | Strong match to biotech, pharma, venture, and CDMO search filters. |
| Geographic targeting potential | High | Useful for Germany, DACH, wider Europe, North America, and APAC targeting. |
| Best outreach approach | Account-based + role-based | Use executive, BD, investment, and scientific job-title filters with partnering keywords. |
| Overall lead quality | Very High | One of the strongest life sciences events for qualified B2B outreach and attendee list value. |
| Best use case | Partnering lead generation | Ideal for sales teams, event-data companies, and B2B agencies targeting life sciences decision-makers. |
| Limitations / risks | Moderate | Current-year full attendee and exhibitor list is not publicly confirmed in the supplied source text. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Biotechnology; Pharmaceuticals; Medical Devices; Venture Capital & Private Equity; Investment Management; Research; Information Technology & Services; Management Consulting; Contract Research | Build a highly relevant life sciences prospect list |
| Departments | Business Development; Partnerships; Corporate Development; R&D; Clinical Development; Regulatory; Investment; Operations; Commercial | Focus on partner-ready and buying-capable functions |
| Seniority | Manager; Senior Manager; Director; Senior Director; VP; CXO; Partner | Prioritize decision-makers and budget influencers |
| Job titles | Chief Business Officer; VP Business Development; Head of Licensing; Director Partnerships; Investment Director; Head of Venture; Head of Regulatory Affairs; Clinical Strategy Lead; CMC Director; Alliance Manager | Capture the core audience for BIO-Europe-style networking |
| Geography | Germany; DACH; Benelux; UK; France; Nordics; United States; Canada; Switzerland; Israel; Singapore; Japan | Reflect the event’s global attendance profile |
| Employee size | 11–50; 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Capture startups, scale-ups, and large pharma alike |
| Keywords | partnering, licensing, biotech, pharma, venture, clinical, regulatory, CDMO, CRO, biomanufacturing, alliance, deal, translational | Match event themes and buying intent |
| Company type | Private; Public; Venture-backed; Corporate-backed; Research-intensive; Service provider | Support flexible lead segmentation |
Suggested Apollo Search Logic: (Biotechnology OR Pharmaceuticals OR Medical Devices OR Venture Capital & Private Equity) AND (Business Development OR Partnerships OR Licensing OR Corporate Development OR Investment Director OR CBO OR CEO OR Regulatory Affairs OR Clinical Development OR CMC) AND geography in Europe, North America, or select APAC life sciences hubs.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| BIO-Europe official event website | Official organizer website | Event name, 2026 date, venue, city, country, organizer, audience scale claim, speaker names, and event positioning | High |
| Informa Connect | Organizer corporate site | Organizer identity and corporate ownership context | High |
| Koelnmesse | Venue website | Venue identification and location verification | High |
| BIO-Europe agenda / programme page | Official agenda / programme | Content themes and participant relevance | High |
| BIO-Europe speakers page | Official speaker listing | Confirmed 2026 featured speaker organizations used in the sample buyer table | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to BIO-Europe — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds